Press release
Immuno Oncology Drugs Market Booming Worldwide with Latest Trend and Future Scope by 2031
Immuno oncology drugs market is expected to grow at a significant CAGR during the forecast period. Cancer is the second biggest cause of mortality globally, following cardiovascular disease. According to research published by the World Health Organization (WHO) in 2018, cancer is responsible for 8.3 million mortalities each year, with 70% of new cancer cases likely to be recorded in the next 20 years. Further, Africa, Asia, Central and South America account for more than 60% of new cancer cases and 70% of cancer mortalities globally. The rise in the prevalence of cancer and the popularity of advanced therapies (biological and targeted pharmacological therapies) are driving the growth of the global immuno oncology drugs market. Furthermore, increased cancer awareness and early cancer screening contribute to the growth of the market. However, the high costs associated with new medication development, as well as the risk of failure and side effects associated with cancer treatment therapies, are hampering the growth of the market.Based on the therapeutic application, the market is segmented into breast cancer, melanoma, lung cancer, blood cancers, renal cell carcinoma, prostate cancer, bladder cancer, and other cancers. Among these, the breast cancer segment is expected to hold a major share in the market during the forecast period, owing to an increase in the number of people affected by the disease and the availability of early detection. On the other hand, the demand for immune-oncology drugs for lung cancer treatment is expected to grow at the fastest rate during the forecast period, owing to higher incidence, an increase in the geriatric population, changes in people's lifestyles, increase in tobacco smoking, passive smoking, which could lead to lung cancer.
To Request a Sample of our Report on Immuno Oncology Drugs Market: https://www.omrglobal.com/request-sample/immuno-oncology-drugs-market
Market Coverage
The market number available for - 2021-2029
Base year- 2020
Forecast period- 2023-2029
Segment Covered
Regions Covered- Globally
Competitive Landscape: Amgen Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Co., and Pfizer Inc.
Global Immuno Oncology Drugs Market Report by Segment
By Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Cancer Vaccines
Immune System Modulators
Others
By Therapeutic Application
Breast Cancer
Melanoma
Lung Cancer
Blood Cancers
Renal Cell Carcinoma
Prostate Cancer
Bladder Cancer
Other Cancers
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
A full Report of Immuno Oncology Drugs Market is Available @ https://www.omrglobal.com/industry-reports/immuno-oncology-drugs-market
Immuno Oncology Drugs Market by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immuno-oncology-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immuno Oncology Drugs Market Booming Worldwide with Latest Trend and Future Scope by 2031 here
News-ID: 3752434 • Views: …
More Releases from Orion Market Research

Pulmonary Function Testing Market Business overview, Upcoming Trends and Analysi …
The global pulmonary function testing market is anticipated to grow at a considerable CAGR of 8.3% during the forecast period. Increasing incidences of lung-related disorders and the numerous advantages offered by pulmonary function testing positively impact the market growth. According to the British Lung Association Foundation 2023 report, nearly 10,000 people in the UK are diagnosed with lung diseases every week. Additionally, pulmonary diseases accounted for more than 70,00,000 hospitals…

Geocomposites Market Value Projected to Expand by 2031
Global geocomposites market is anticipated to grow at a significant CAGR of 11.8% during the forecast period (2024-2031). The rising need for infrastructure development especially in emerging economies is a significant driver for the geocomposites market. According to the World Bank, global infrastructure spending is projected to reach $9.0 trillion annually by 2040, creating a robust demand for geocomposites in road construction, bridges, and tunnels. Additionally, the demand for housing and transportation…

Piezoresistive Pressure Sensors Market Will Exhibit an Impressive Expansion by 2 …
In piezoresistive pressure sensors, the measuring element is a silicon-based Wheatstone-Bridge. It extends minimally under pressure changing the electrical resistance in this way. This effect is commonly referred to as piezoresistive effect.
Get Free Sample link @ https://www.omrglobal.com/request-sample/piezoresistive-pressure-sensors-market
These sensors are highly used in automotive industry for several applications including tire pressure monitoring systems (TPMS), airbag deployment systems, and engine management systems. Piezoresistive pressure sensors are a popular choice in these applications…

Isoprene Rubber Latex Market to Witness Astonishing Growth by 2031
Global isoprene rubber latex market is anticipated to grow at a considerable CAGR of 8.4% during the forecast period (2024-2031). The growing adoption of this material in the manufacturing of medical gloves, catheters, and other healthcare goods owing to their biocompatibility and elasticity is a key factor driving the global market growth. Due to its superior bonding properties, isoprene rubber latex is used in sealants and adhesives in the construction industry. Due…
More Releases for Immuno
Organic Dispersion To Drive The Immuno-Oncology Market
The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology therapies can leverage patients' immune system and re-program the same to attack cancer cells, providing a safe and effective alternative. There has been an increasing demand for immuno-oncology therapy as several traditional methods used in the treatment of cancer such as chemotherapy, radiation therapy, and surgery, etc. carry the risk…
Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications.
The research goes into great detail on several aspects that have been studied as…
Next Gen Immuno-Oncology Congress - 4th Annual MarketsandMarkets
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.
Register as a Delegate at https://www.reportsnreports.com/events/4th-annual-marketsandmarkets-next-gen-immuno-oncology-congress/register
o 30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on…
Cell Therapy to Transform Immuno Oncology Landscape
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Less than 4 Weeks until Immuno-Therapy Experts Gather at the Immuno-Oncology Con …
There’s just under 4 weeks until SMi’s Immuno-Oncology Conference commences in London on the 26th and 27th September (www.immuno-oncology-conference.com/openpr).
The event aims to propagate thought-provoking discussions about the future of Immuno-Oncology between industry leaders, and update delegates on current key areas for development, advancements in therapy and revisions of regulations.
The study of immuno-oncology has been ever-present in recent news, with biomarkers in melanoma having been recently identified by Dana-Farber Cancer Institute…
Immuno-Oncology Conference, London – agenda released
Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.
SMi's Immuno-Oncology Conference (26 – 27 September 2018, London, UK) will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
Agenda - Valuable time is spent to…